ENOblock, a unique small molecule inhibitor of the non-glycolytic functions of enolase, alleviates the symptoms of type 2 diabetes

Haaglim Cho(Max Planck Institute for Heart and Lung Research), Darren R. Williams(Gwangju Institute of Science and Technology)
Scientific Reports
March 8, 2017
Cited by 65


Related Papers